~~<i id='2819B2B9F3'><strike id='2819B2B9F3'><tt id='2819B2B9F3'><pre id='2819B2B9F3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

entertainment

author：hotspot 2025-10-01 14:59:57 - browse：35465

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： SCOTUS questions limit to govt efforts to fight misinformation

focus

Wikipedia

focus

hotspot

leisure time

MollyFerguson/STATIwaswrongaboutGeron.Foryears,I’vebelieved—anddeclaredpublicly—thatGeron’sefforttod

WSS

A clever new way to fix Medicaid and graduate medical education

Stop the failed accountable care organization experiment

White House calls on federal agencies to crack down on AI abuses

Free speech concerns arise in wake of journal editor Eisen's firing

More doctors should go into startup world

App could help diagnose ear infections more accurately — and at home

explore

entertainment

focus

The cancer drug shortage isn’t new — and neither are the solutions

MoonLake credibility takes another hit with mid

Dobbs anniversary: the lost opportunity of abortion as health care

Physicians and social media: If you see something, say something?

Affirmative action in medical school literally saved lives

HPV cancer vaccine study demonstrates efficacy

Walensky prepares to leave CDC — and Congress — behind

Excited delirium, Elijah McClain, and emergency physicians

After affirmative action ruling, medical educators look to 'holistic review'

Health AI adoption puts security, privacy startups on investors' radar

Wikipedia

Medicare solvency divides Republicans at the presidential debate

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Creating egg and sperm cells from stem cells raises ethical issues

The Sacklers, horror, and ‘The Fall of the House of Usher’

AstraZeneca to buy developer of next

White House calls on federal agencies to crack down on AI abuses

focus

hotspot

hotspot

leisure time